Page 110 - AN-4-1
P. 110

Advanced Neurology                                                       TDP-43 regulates IFN1 production



               doi: 10.4049/jimmunol.1300740                      doi: 10.1038/nn.4000
            19.  Gorrie GH, Fecto F, Radzicki D, et al. Dendritic spinopathy   29.  Xu D, Jin T, Zhu H, et al. TBK1 suppresses RIPK1-driven
               in transgenic mice expressing ALS/dementia-linked mutant   apoptosis and inflammation during development and in
               UBQLN2. Proc Natl Acad Sci U S A. 2014;111(40):14524-  aging. Cell. 2018;174(6):1477-1491.
               14529.                                             doi: 10.1016/j.cell.2018.07.041
               doi: 10.1073/pnas.1405741111                    30.  Liu W, Wang Z, Liu L, et al. LncRNA Malat1 inhibition of TDP
                                                                                                            43
            20.  Chen T, Huang B, Shi X, Gao L, Huang C. Mutant   cleavage suppresses IRF3-initiated antiviral innate immunity.
               UBQLN2 P497H  in motor neurons leads to ALS-like phenotypes   Proc Natl Acad Sci U S A. 2020;117(38):23695-23706.
               and defective autophagy in rats. Acta Neuropathol Commun.      doi: 10.1073/pnas.2003932117
               2018;6(1):122.
                                                               31.  Yu CH, Davidson S, Harapas CR,  et al. TDP-43 triggers
               doi: 10.1186/s40478-018-0627-9                     mitochondrial DNA release via mPTP to activate cGAS/
            21.  Wu Q, Liu M, Huang C,  et al. Pathogenic Ubqln2 gains   STING in ALS. Cell. 2020;183(3):636-649.
               toxic properties to induce neuron death. Acta Neuropathol.      doi: 10.1016/j.cell.2020.09.020
               2015;129(3):417-428.
                                                               32.  Ma X, Helgason E, Phung QT, et al. Molecular basis of tank-
               doi: 10.1007/s00401-014-1367-y                     binding kinase 1 activation by transautophosphorylation.
            22.  Pilli M, Arko-Mensah J, Ponpuak M, et al. TBK-1 promotes   Proc Natl Acad Sci U S A. 2012;109(24):9378-9383.
               autophagy-mediated antimicrobial defense by controlling      doi: 10.1073/pnas.1121552109
               autophagosome maturation. Immunity. 2012;37(2):223-234.
                                                               33.  Ahmad L, Zhang SY, Casanova JL, Sancho-Shimizu V.
               doi: 10.1016/j.immuni.2012.04.015                  Human TBK1: A gatekeeper of neuroinflammation. Trends

            23.  Le NTT, Chang L, Kovlyagina I, et al. Motor neuron disease,   Mol Med. 2016;22(6):511-527.
               TDP-43 pathology, and memory deficits in mice expressing      doi: 10.1016/j.molmed.2016.04.006
               ALS-FTD-linked UBQLN2 mutations. Proc Natl Acad Sci U
               S A. 2016;113(47):7580-7589.                    34.  Trinchieri G. Type I interferon: Friend or foe? J Exp Med.
                                                                  2010;207(10):2053-2063.
               doi: 10.1073/pnas.1608432113
                                                                  doi: 10.1084/jem.20101664
            24.  Xia Y, Yan LH, Huang B, Liu M, Liu X, Huang C. Pathogenic
               mutation of UBQLN2 impairs its interaction with UBXD8   35.  Yu J, Zhou X, Chang M,  et al. Regulation of T-cell
               and disrupts endoplasmic reticulum-associated protein   activation and migration by the kinase TBK1 during
               degradation. J Neurochem. 2014;129(1):99-106.      neuroinflammation. Nat Commun. 2015;6:6074.
               doi: 10.1111/jnc.12606                             doi: 10.1038/ncomms7074
            25.  Dugger BN, Dickson DW. Pathology of neurodegenerative   36.  Zhao W. Negative regulation of TBK1-mediated antiviral
               diseases. Cold Spring Harb Perspect Biol. 2017;9(7):a028035.  immunity. FEBS Lett. 2013;587(6):542-548.
               doi: 10.1101/cshperspect.a028035                   doi: 10.1016/j.febslet.2013.01.052
            26.  Smethurst  P,  Sidle  KC,  Hardy  J.  Review:  Prion-like   37.  McCoy CE, Carpenter S, Pålsson-McDermott EM, Gearing LJ,
               mechanisms of transactive response DNA binding protein   O’Neill LA. Glucocorticoids inhibit IRF3 phosphorylation in
               of 43 kDa (TDP-43) in amyotrophic lateral sclerosis (ALS).   response  to  Toll-like  receptor-3 and  -4  by  targeting  TBK1
               Neuropathol Appl Neurobiol. 2015;41(5):578-597.    activation. J Biol Chem. 2008;283(21):14277-14285.
               doi: 10.1111/nan.12206                             doi: 10.1074/jbc.M709731200
            27.  Ince PG, Highley JR, Kirby J,  et  al. Molecular pathology   38.  Sin WX, Yeong JP, Lim TJF, Su IH, Connolly JE, Chin KC.
               and genetic advances in amyotrophic lateral sclerosis: An   IRF-7 mediates type  I IFN responses in endotoxin-
               emerging molecular pathway and the significance of glial   challenged mice. Front Immunol. 2020;11:640.
               pathology. Acta Neuropathol. 2011;122(6):657-671.     doi: 10.3389/fimmu.2020.00640
               doi: 10.1007/s00401-011-0913-0                  39.  Ramesh N, Pandey UB. Autophagy dysregulation in
                                                                  ALS: When protein aggregates get out of hand. Front Mol
            28.  Freischmidt A, Wieland T, Richter B, et al. Haploinsufficiency
               of TBK1 causes familial ALS and fronto-temporal dementia.   Neurosci. 2017;10:263.
               Nat Neurosci. 2015;18(5):631-636.                  doi: 10.3389/fnmol.2017.00263







            Volume 4 Issue 1 (2025)                        104                               doi: 10.36922/an.6272
   105   106   107   108   109   110   111   112   113   114   115